VTA Dopaminergic Neuron Modulation for Immune Response Control

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current understanding of the central mechanisms mediated by the dopaminergic network in the brain, particularly its impact on the immune response, is limited, and existing treatments for cancer and immune modulation have immunosuppressive effects that are not fully understood.

Innovation Solution

Activating or inhibiting dopaminergic neurons in the Ventral Tegmental Area (VTA) using methods such as transcranial magnetic stimulation (TMS) or administering dopamine agonists/antagonists that cross the blood-brain barrier, to modulate the immune response and treat cancer.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If dopaminergic neurons in the VTA are activated to modulate immune response, then immune cell activity and abundance are improved, but the mechanism and control precision are limited due to lack of understanding of central mechanisms

Engineering Contradiction:

Improveimmune response modulation efficacyVSAvoidmechanism understanding

Core Design Contradiction:

ReliabilityVSDifficulty of detecting and measuring

Solution Approach 1:

The patent replaces traditional mechanical/pharmacological stimulation methods with optogenetic technology to activate dopaminergic neurons. By using light-sensitive channels (Channelrhodopsin-2) expressed specifically in VTA dopaminergic neurons, the invention achieves precise temporal and spatial control of neuronal activation, enabling reliable immune response modulation while overcoming the limitations of mechanistic understanding through direct causal manipulation.

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

2Reliability

If existing treatments are used for cancer and immune modulation, then some therapeutic effect is achieved, but immunosuppressive effects occur that are not fully understood

Engineering Contradiction:

Improvetherapeutic effectVSAvoidimmunosuppressive effects

Core Design Contradiction:

ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent extracts and isolates the specific dopaminergic neuronal pathway in the VTA that mediates immune modulation. By using optogenetic tools to selectively activate only these neurons with light stimulation, the invention separates the beneficial immune-enhancing effects from the harmful immunosuppressive side effects associated with conventional treatments, achieving cancer therapy through a purified neural circuit mechanism.

Inventive Principle:

Principle #2Taking out (Extraction)

Solution Approach 2:

The patent introduces optogenetic channels as an intermediary mechanism between external light stimulation and dopaminergic neuronal activation. This intermediary allows precise control of immune modulation without the uncontrolled side effects of direct pharmacological intervention, enabling therapeutic cancer treatment while avoiding harmful immunosuppression through a controllable intermediate step.

Inventive Principle:

Principle #24Intermediary (Mediator)

3Ease of operation

If transcranial magnetic stimulation or dopamine agonists are administered to activate VTA neurons, then immune response is modulated, but the precision and targeting of specific neurons is reduced

Engineering Contradiction:

Improvemethod applicabilityVSAvoidneuron targeting precision

Core Design Contradiction:

Ease of operationVSMeasurement precision

Solution Approach 1:

The patent replaces crude mechanical stimulation methods (transcranial magnetic stimulation) and non-specific pharmacological approaches (dopamine agonists) with optogenetic technology. By expressing light-sensitive channels specifically in VTA dopaminergic neurons and delivering light through implanted fibers, the invention achieves millisecond precision and cell-type specificity, overcoming the imprecision of mechanical and chemical methods while maintaining operational feasibility.

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach effectively modulates the immune response by altering the activity and abundance of various immune cells, such as NK cells, T-cells, and dendritic cells, and has been shown to treat melanoma and carcinoma by reducing tumor size and altering immune cell populations.

Implementation Method 1

Activating or inhibiting dopaminergic neurons in the Ventral Tegmental Area (VTA) using methods such as transcranial magnetic stimulation (TMS)

Methodology Applied

Scientific EffectElectromagnetic induction: Electromagnetic Induction

Data Source

PatentUS12201628B2Neuronal modulation

Publication Date: 2025.01.21 TECHNION RES & DEV FOUND LTD

AI summary

A method for modulating an immune response by activating or inhibiting dopaminergic neurons in the Ventral Tegmental Area (VTA) is provided. Modulation is achieved by modulating the activity, the abundance or both of: a natural killer cell, a CD8 T-cell, a CD4 T-cell, a B-cell, a dendritic cell, a macrophage, a granulocyte, or their combination.